2016
DOI: 10.1016/j.jinf.2015.11.008
|View full text |Cite
|
Sign up to set email alerts
|

Recent advances in pathophysiology and biomarkers of sepsis-induced acute kidney injury

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
46
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 69 publications
(49 citation statements)
references
References 138 publications
2
46
0
Order By: Relevance
“…Sepsis-induced AKI accounts for nearly 50% of cases of AKI in the ICU (14). Moreover, AKI is the leading cause of death in the ICU (15).…”
Section: Discussionmentioning
confidence: 99%
“…Sepsis-induced AKI accounts for nearly 50% of cases of AKI in the ICU (14). Moreover, AKI is the leading cause of death in the ICU (15).…”
Section: Discussionmentioning
confidence: 99%
“…In systemic sepsis, bacterial products termed PAMPs (pathogen-associated molecular pattern molecules; eg, endotoxin) are described to bind to pattern recognition receptors on leukocytes and most other cell types (the classic receptors being Toll-like receptors [TLRs]), resulting in activation of multiple cell types. 27,28 Circulating activated leukocytes reportedly extravasate into the tissue of target organs after being exposed to chemokines and adhesion molecules (eg, ICAM-1, E-selectin) on the surface of the activated endothelium (and chemokines in the tissue). 29 The release of proinflammatory cytokines from these leukocytes, in combination with activated tissue macrophages, are discussed as a major event leading to organ/tissue dysfunction and injury that occurs in sepsis in multiple species and equine laminitis.…”
Section: Discussionmentioning
confidence: 99%
“…Toll‐like receptor 4 as one of the major outer membrane components of Gram‐negative bacteria is a major player in the LPS‐induced AKI inflammatory response . The TLR4 signalling pathway is activated at the initiation of LPS‐induced inflammatory response, then its downstream pathway NF‐κB is activated, and NF‐κB activation induces the release of inflammatory factors . When the inflammatory factors in the cells are released, the inactive NF‐κB in the cytoplasm is rapidly transferred to the nucleus to regulate the inflammatory cytokines .…”
Section: Discussionmentioning
confidence: 99%
“…[4] The TLR4 signalling pathway is activated at the initiation of LPS-induced inflammatory response, then its downstream pathway NF-jB is activated, and NF-jB activation induces the release of inflammatory factors. [14] When the inflammatory factors in the cells are released, the inactive NF-jB in the cytoplasm is rapidly transferred to the nucleus to regulate the inflammatory cytokines. [15,16] Therefore, the TLR4 signalling pathway can be considered an effective therapeutic target for AKI induced by LPS.…”
Section: Discussionmentioning
confidence: 99%